ASM’s Premier Annual Conference on Infectious
Diseases and Antimicrobial Agents
C O M I N G T H I S N O V E M B E R
Peer-Reviewed
OFFICIAL PEER-REVIEWED HIGHLIGHTS FROM THE
Clinical T rial Highlights
Translational Research
Therapeutic Updates
ALSO IN THIS ISSUE tt Hot Topics in Vaccines Clinical TBehind Infectious Diseaserial Highlights – The Science
t Novel Approaches to Antibacterial Drug Discovery Infectious Dis
ease Genomics : Individual Variability,
New Opportunitite
s
Technological advances now enable compar
isons of mor e than a half a million genetic
variants in subjects with disease
and popula tion controls. A large number of no
vel genetic loci involved in susceptibility
to common immune-related diseases
, such as rheumatoid ar thritis and inflamm
atory bowel disease, have been
identified through genome-w ide associa
tion studies
. More recently, this methodology h as been
successfully applied to identify loci in
volved in infectious disease susceptibility
[Vannberg FO et al.
Immunol Rev
2011]. See page 4.
52nd Interscience Conference on Antimicrobial
Agents and Chemotherapy
September 9 - 12, 2012 San Francisco,
California, USA INFEC
TIOUS DISEASE
Distribution of this independent report is supported by
Scan for the
ICAAC 2011 edition
Want to know more?
Official Peer-Reviewed Highlights
7RSUHVHDUFKNH\ILQGLQJVDQGSUDFWLFHFKDQJLQJXSGDWHV
&RQWHQWJXLGHGE\,&$$&3URJUDP&RPPLWWHH
$UWLFOHVZULWWHQVWULFWO\IURPSULPDU\VRXUFHGDWD
3HHUUHYLHZHGE\LQGHSHQGHQWH[SHUWV
ICAAC Program Committee . . . 4
Welcome Letter . . . 5
Corporate Supporters . . . 6
ICAAC Mobile App . . . 6
Schedule-at-a-Glance . . . 7
ICAAC Awards and Lectures . . . 8
Opening Keynote Session . . . 8
ICAAC Lecture . . . 8
Cubist-ICAAC Award and Lecture . . . 8
ICAAC Program Committee Awards . . . 9
ICAAC Young Investigator Awards . . . 10
Poster Walks . . . 11
Grant and Travel Grant Recipients . . . 13
ICAAC ID Fellows Grant Program . . . 13
ASM Infectious Diseases (ID) Fellow Travel Grants . . . 14
ASM Student and Post-Doctoral Fellow Travel Grants . . . . 15
American Society for Microbiology Products and Services . . . . 17
Career Connections . . . 17
ASM Journals . . . 17
ASM Press Bookstore . . . 17
Membership . . . 17
Press Room and ICAAC Live . . . 17
Convention Center Floor Plans . . . 18
Hotel Information . . . 20
Hotel Map . . . 21
Shuttle Information . . . 22
General Information . . . 23
Abstract Compilations . . . 23
Abstracts on CD-ROM . . . 23
Americans with Disabilities Act . . . 23
ATM Machines . . . 23
Badge Policies . . . 23
Business Center . . . 24
Cameras and Recordings . . . 24
Certificate of Attendance . . . 24
Child Safety . . . 24
Coat and Baggage Check . . . 24
Cooperating Organizations . . . 24
E-Central . . . 24
Exhibit Hall . . . 25
ExpoCard . . . 25
First Aid . . . 25
Food and Beverage Services . . . 25
Future Meetings Booth . . . 25
Housing . . . 25
Information Booths . . . 25
Lost and Found . . . 26
Messages . . . 26
Multimedia Sales . . . 26
Nursing Room . . . 26
Parking . . . 26
Poster Information . . . 26
Poster Walks . . . 26
Program Changes . . . 26
Registration Hours . . . 26
Satellite Symposia . . . 26
Sessions and Room Capacity . . . 26
Shipping . . . 27
Shuttle Service . . . 27
Smoking Policy . . . 27
Speaker Ready Room . . . 27
Telephone Numbers . . . 27
Transportation . . . 27
Continuing Education . . . 28
Glossary . . . 30
Scientific Sessions . . . 31
Workshops . . . 31
Sunday . . . 37
Monday . . . 71
Tuesday . . . 127
Wednesday . . . 183
Indices . . . 207
Abstract Authors Index . . . 207
Keyword Index . . . 261
Program Grid . . . 279
Late-breakers . . . 295
Late-breaker Presentations . . . 295
Late-breaker Abstracts . . . .305
Late-breaker Author Index . . . 339
Late-breaker Keyword Index . . . 345
ICAAC Headquarters:
American Society for Microbiology Meetings & Exhibits
1752 N Street, NW Washington, DC 20036-2904 Telephone: (202) 737-3600 Fax: (202) 942-9340 E-mail: [email protected] Internet: www.icaac.org
Copyright © 2012 American Society for Microbiology Printed in the United States of America
Judith A. Aberg, MD
New York University School of Medicine, New York, NY
David Michael Aronoff, MD
University of Michigan Health System, Ann Arbor, MI
Emily Blumberg, MD
University of Pennsylvania, Philadelphia, PA
Guy Boivin, MD
Laval University, Quebec, Canada
Robert A. Bonomo, MD
VA Medical Center, Cleveland, OH
Patricia A. Bradford, PhD
AstraZeneca Pharmaceuticals, Waltham, MA
Angela M. Caliendo, MD, PhD
Emory University Hospital, Atlanta, GA
Karen Carroll, MD
Johns Hopkins University School of Medicine, Baltimore, MD
Morven S. Edwards, MD
Baylor College of Medicine, Houston, TX
Joseph J. Eron, Jr., MD
University of North Carolina, Chapel Hill, NC
Niels Fridmodt-Moller, MD
Statens Serum Institute, Copenhagen, Denmark
Carlo Giaquinto, MD
University of Padova, Padova, Italy
Loreen Herwaldt, MD
University of Iowa College of Medicine, Iowa City, IA
Stephen G. Jenkins, PhD
Weill Cornell Medical College, New York, NY
John A. Jernigan, MD
Centers for Disease Control and Prevention, Atlanta, GA
Kevin C. Kain, MD
University of Toronto, Toronto, Canada
Laurent Kaiser, MD
University Hospitals of Geneva, Geneva, Switzerland
Alan Magill, MD
Walter Reed Army Medical Institute of Research, Silver Spring, MD
Lesley McGee, PhD
Centers for Disease Control and Prevention, Atlanta, GA
Jean-Michel Molina, MD, PhD
Hospital Saint Louis, Paris, France
Patrice Nordmann, PhD
Hospital Bicetre, Paris, France
Malcolm G. P. Page, PhD
Basilea Pharmaceuticia, Basel, Switzerland
Robin Patel, MD
Mayo Clinic College of Medicine, Rochester, MN
John Perfect, MD
Duke University Medical Center, Durham, NC
Laura J.V. Piddock, PhD
University of Birmingham, Birmingham, United Kingdom
Liise-anne Pirofski, MD
Albert Einstein College of Medicine, Bronx, NY
Johann Pitout, MD
Calgary Laboratory Services, Calgary, Canada
Didier Pittet, MD
University of Geneva, Geneva, Switzerland
Michael J. Pucci, PhD
Achillion Pharmaceuticals, New Haven, CT
Vincent Racaniello, PhD
Columbia University Medical Center, New York, NY
Jesús Rodriguez Baño, MD, PhD
Hospital Universitario Virgen Macarena, Sevilla, Spain
Keith A. Rodvold, PhD
University of Illinois, Chicago, IL
Wing-Hong Seto, MD
Queen Mary Hospital, Hong Kong, China
Shiranee Sriskandan, FRCP, PhD
Imperial College Faculty of Medicine, London, United Kingdom
Tania C. Sorrell, MD
University of Sydney, Westmead, Australia
M. Lindsay Grayson, MD, Chair
Austin Hospital, Melbourne, Australia
Craig E. Rubens, MD, PhD, Vice Chair
Seattle Children’s Hospital Research Institute, Seattle, WA
Conference on Antimicrobial Agents and Chemotherapy, we invite you to take full advantage of all that ICAAC has to offer. Scheduled throughout the four days of ICAAC, the premier conference on antimicrobial agents and infectious diseases, is a line-up of oral and poster presentations showcasing the latest-breaking science and lectures from top researchers from around the globe.
The ICAAC Program Committee has designed a program of the highest quality to facilitate the exchange of new information among healthcare professionals, particularly physicians, clinical microbiologists, researchers, pharmacists and trainees specializing in infectious diseases. Two hundred and fifty-five sessions have been scheduled including: the Opening Keynote session, covering cutting edge issues related to diagnostics, viral hepatitis, and new drug discovery; the ICAAC Lecture “Fungal Disease in the 21st Century”; the Cubist-ICAAC Award Lecture “Antiviral Chemotherapy: Astonishing Progress and Formidable Pushback—The Ying and Yang of Host-Viral Interactions”; ten interactive symposia; 36 Meet-the-Experts sessions; and 70 didactic symposia. In addition, on Sunday afternoon there will be a Poster Summary reporting on Early New Antimicrobial Agents and a Literature Review to provide an update on infectious diseases. From over 1,700 accepted abstract submissions, the Program Committee has organized 107 poster sessions, 26 slide sessions and seven state-of-the-art mini-lectures. Late-breaker abstracts will be presented during applicable slide and poster sessions rather than in separate Late-breaker sessions. The Late-breaker abstracts and presentation times have been printed on page 295 of this and are posted online at www.icaac.org.
The complement of abstract sessions and invited sessions allow for the presentation of new and important developments in the therapy, prevention, pathogenesis, epidemiology, immunology and diagnosis of both established and emerging infectious diseases. Detailed session
descriptions are included in this Final Program. The Program Committee welcomes your feedback regarding all aspects of the meeting. This feedback will be used to plan future ICAACs that meet all of your expectations. Surveys for individual sessions are available at E-Central. These surveys will also be available online for one year after the meeting. In addition, you will receive via e-mail, an evaluation survey composed of questions that cover many aspects of the conference. Your responses are vital in assisting the Program Committee with their preparations for ICAAC 2013, which will be held September 10-13, 2013, in Denver, CO.
We hope that you enjoy your time in San Francisco and at ICAAC 2012. We are certain you will return home with new information that you can immediately put to use in your offices, classrooms and laboratories to improve healthcare and the management of infectious diseases.
M. Lindsay Grayson, MD Craig E. Rubens, MD, PhD
Chair, ICAAC Program Committee Vice-Chair, ICAAC Program Committee
M. Lindsay Grayson
The ICAAC 2012 App is compatible with iPhone, BlackBerry, and Android smartphones, as well as iPad and most tablets.
Scan above using your device’s barcode scanner application for easy download. ICAAC 2012
For BlackBerry, Android, and all other web-enabled smartphones:
Point your browser to m.core-apps.com/TriStar-ICAAC12. On this web-based mobile site, you will be directed to the proper download version for your device type.
For iPhone, iPod Touch, and iPad users:
From your handheld device, go to the iTunes App Store and search for “ICAAC” or “ICAAC 2012” to locate the app. Click on the “free” button, which will take you to the install screen. Next, download the ICAAC 2012 App as you would any other application from the iTunes App Store. It’s that easy.
Features include:
t
Interactive program & course schedules
t
Customizable calendar & itinerary builder
t
Exhibitor listing with interactive booth map
t
Social media interaction
t
Meeting alerts
Get 24-hour access to unique,
on-the-go meeting information,
maps, and networking.
INTRODUCING
THE ICAAC
2012 APP!
NOW
AVAILABLE!
DOWNLOADING THE APP IS EASY
ICAAC 2012
Supporters
>
Booth 1001
Aisle Signs
ICAAC 2012 Peer Reviewed Highlights Report
Booth 700
Abstracts on CD-ROM
iPosters™
Booth 1300
Expocards
ID Fellows Grant Program
Booth 1101
ID Fellows Grant Program
Booth 1301
ID Fellows Grant Program
ID Fellows Grant Program
Saturday Sunday Monday Tuesday Wednesday
September 8 September 9 September 10 September 11 September 12
Registration 12:00 p.m. - 5:00 p.m. 6:30 a.m. - 5:00 p.m. 6:30 a.m. - 5:00 p.m. 6:30 a.m. - 5:00 p.m. 6:30 a.m. - 9:00 a.m.
Workshops* 8:30 a.m. - 4:30 p.m.
Infectious Diseases 7:00 a.m. - 9:00 a.m.
101 for Fellows Ages 18-88
Keynote Session 9:30 a.m. - 11:30 a.m.
Meet-the-Experts 7:00 a.m. - 8:15 a.m. 7:00 a.m. - 8:15 a.m. 7:00 a.m. - 8:15 a.m. 5:45 p.m. - 7:00 p.m. 5:45 p.m. - 7:00 p.m.
Symposia 4:00 p.m. - 6:00 p.m. 8:30 a.m. - 10:30 a.m. 8:30 a.m. - 10:30 a.m. 9:15 a.m. - 11:15 a.m. 11:15 a.m. - 12:45 p.m. 11:15 a.m. - 12:45 p.m.
2:00 p.m. - 4:00 p.m. 2:00 p.m. - 4:00 p.m.
Slide Sessions 4:00 p.m. - 6:30 p.m. 8:30 a.m. - 11:00 a.m. 8:30 a.m. - 11:00 a.m. 9:15 a.m. - 11:45 a.m. 1:30 p.m. - 4:00 p.m. 1:30 p.m. - 4:00 p.m.
Poster Sessions 11:30 a.m. - 1:30 p.m. 11:15 a.m. - 1:15 p.m. 11:15 a.m. - 1:15 p.m. 9:15 a.m. - 11:15 a.m.
Exhibits and Posters 11:30 a.m. - 4:30 p.m. 10:30 a.m. - 4:30 p.m. 10:30 a.m. - 4:30 p.m.
Special Lectures and 1:45 p.m. - 3:45 p.m. 4:30 p.m. - 5:30 p.m. 4:30 p.m. - 5:30 p.m. 8:00 a.m. - 9:00 a.m.
Award Presentations Literature Review ICAAC Lecture Cubist-ICAAC Plenary Session Session & Poster Award Lecture
Summary Session
Commercially-Supported Educational Activities
Keynote Session
Sunday, September 9 | 9:30 a.m. - 11:30 a.m. | Hall E
Emerging New Issues in the Management of Hepatitis C Infection
Charles M. Rice, PhD
The Rockefeller Univ., New York-Presbyterian Hosp., Weill Cornell Med. Coll., New York, NY
The Impact of Emerging New Diagnostic Laboratory Techniques on Clinical Infectious Disease
Franklin R. Cockerill III, MD
Mayo Clinic, Rochester, MN
Prospects for New Antibiotics
Christopher T. Walsh, PhD
Harvard Med. Sch., Boston, MA
ICAAC Lecture
Monday, September 10 | 4:30 p.m.– 5:30 p.m. | Room 103
Fungal Disease in the 21st Century
Arturo Casadevall, MD, PhD
Albert Einstein Coll. of Med., Bronx, NY
Cubist-ICAAC Award and Lecture
Tuesday, September 11 | 4:30 p.m. - 5:30 p.m. | Room 103
Supported by Cubist Pharmaceuticals
Antiviral Chemotherapy: Astonishing Progress and Formidable Pushback— The Ying and Yang of Host-Viral Interactions
Lawrence Corey, MD
Fred Hutchinson Cancer Research Center, Seattle, WA
ASM’s premier award honoring outstanding accomplishment in antimicrobial research is presented to Lawrence Corey. An internationally renowned expert in virology, immunology and vaccine development, Corey’s research focuses on herpes viruses, HIV, and other viral infections, particularly those associated with cancer.
Corey is the President and Director of the Fred Hutchinson Cancer Research Center. He earned his bachelor’s and medical degrees from the University of Michigan, and completed infectious diseases training at the University of Washington School of Medicine. He joined the faculty of the University of Washington in 1978, where he remains today as a Professor of Laboratory Medicine and holder of the Lawrence Corey Endowed Chair in Medical Virology. Corey is also an infectious disease physician at Seattle Cancer Care Alliance and the principal investigator of the Hutchinson Center-based HIV Vaccine Trials Network (HVTN), an international collaboration of scientists and institutions that combines clinical trials and laboratory-based studies to accelerate the development of HIV vaccines.
Corey will deliver the Cubist-ICAAC Award Lecture,“Antiviral Chemotherapy: Astonishing Progress and Formidable Pushback—The Ying and Yang of Host-Viral Interactions,” on September 11 at 4:30 p.m.
ICAAC
Awards and Lectures
These awards were established for the purpose of encouraging the presentation of quality
research through outstanding abstract preparation. Following the review of all submitted
abstracts, the ICAAC Program Committee has a meeting to discuss the most interesting
submissions and is pleased to announce the following six recipients. You are encouraged to
attend their presentations.
Pathogenesis of Microbial Diseases
Ana García-Reyne, MD, PhD
Univ. Hosp. 12 Octubre, Madrid, Spain
Influence of Cytomegalovirus (CMV) Disease in the Development of Cardiac Allograft Vasculopathy (CAV) in Heart Transplants Recipients (HTR) through the Application of the New ISHLT (International Society of Heart Transplantation) Coronary Angiographic Criteria
Slide Session 116, Presentation T-1071
Epidemiology of Infection
David J. Templeton, PhD
Kirby Inst., Univ. of New South Wales, Sydney, Australia
Prevalence and Correlates of Vaccine-Preventable Anal Human Papillomavirus Genotypes in Australian Homosexual Men
Poster Session 027, Presentation L2-301
Therapy and Prevention of Microbial Disease
Au H. Duong, BS
Univ. California San Francisco, San Francisco, CA
Efficacy of Human Intravenous Immunoglobulin (IVIG) for the Treatment of Lethal Necrotizing Pneumonia Caused by Hypervirulent Community-Associated Methicillin- Resistant Staphylococcus aureus
Slide Session 196, Presentation B-1735
Clinical Microbiology and Diagnosis
Stefano Giulieri, MD
Univ. of Lausanne, Lausanne, Switzerland
Is CSF Lactate the Best Parameter for Discriminating Bacterial from Viral Community Acquired Meningitis?
Slide Session 158, Presentation L1-1221
Resistance: Mechanisms and Consequences
Alicia E. Farinati, Sr., MD
Salvador Univ., Buenos Aires, Argentina
Prevalence of Naturally Occurring Hepatitis C Virus (HCV) Variants with Primary Resistance to the Direct-Acting Antivirals (DAA): Analysis of 722 Complete Genome Sequences and 307 NS3/4A and NS5B Partial Sequences
Slide session 160, Presentation V-1237
Immunology of Infection
Emmanuel Faure, PhD
Lille 2 Univ. Hosp., Lille, France
IPAF-Inflammasome Null Mice are Protected from Pseudomonas aeruginosa-Induced Acute Lung Infection
William P. Hanage, PhD
Harvard School of Public Health, Boston, MA
Honored for his work studying the epidemiology and evolution of infectious disease, Hanage received his PhD from Imperial College London where he studied host microbial interactions. Hanage continued to the University of Oxford and later Imperial College London, where he studied the molecular epidemiology of bacterial pathogens. Especially interested in subjects that combine clinical importance with fundamental biological questions, Hanage looks at questions like how pathogens respond to novel selective pressures in the form of antimicrobials and vaccines.
Andrew Lee Lovering, PhD
University of Birmingham, Edgbaston, Birmingham, United Kingdom
Lovering is recognized for his seminal work on the structural biology and biochemistry of the proteins that synthesize and modify cell walls in bacteria. Lovering earned his PhD in Biosciences from Birmingham Uni-versity, where he used x-ray crystallography to detail the mechanism of action of two enzymes involved in cancer therapies— one a bacterial nitroreductase used in gene therapy of solid tumors, and the other a target for a cell differentiation approach tackling acute myeloid leukemia. He then took a postdoctoral position at the University of British Columbia working on antibacterial research. Lovering now focuses on deciphering the molecular basis of bacterial predation by Bdellovibrio bacteriovorus, a phenomenon that may lead to its exploitation as a “living antibiotic.”
María Soledad Ramírez, PhD
National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina
Ramírez is honored for her outstanding work in the area of integron participation in gene capture and dissemination. Before earning her PhD at the University of Buenos Aires, Ramírez underwent clinical research training at the Fundación Favaloro. After receiving her PhD, Ramírez received a CONICET Postdoctoral Fellowship, followed by a Fulbright-CONICET Research Fellowship. She has exten-sive experience in the study of the mechanisms of antimicrobial resistance, both in the biochemical characterization and the genetic analysis of the structures associated with the encoding genes.
Mario L. Santiago, PhD University of Colorado, Denver
Santiago’s outstanding work in virology includes field-based HIV epidemiology studies and manipulating innate immunity in his efforts to explore innovative new ways to approach the challenge of the HIV vaccine. Before receiving his PhD in Microbiology at the University of Alabama- Birmingham, Santiago worked at the NIH-sponsored Tropical Medicine Research Center in the Philippines and as a Fogarty AIDS International Research fellow at Brown University. He completed postdoctoral fellowships at the University of Alabama-Birmingham and the University of California, San Francisco. He now works on the interplay between innate retroviral restriction and adaptive immunity in mice, monkeys and humans, with a conceptual focus on HIV vaccine development, host genetics of retrovirus resistance, and interferon-based antiretroviral therapy.
David M. Tobin, PhD
Duke University School of Medicine, Durham, NC
Tobin is recognized for his work in infectious disease therapeutics. He received his PhD at the University of California, San Francisco, where he defined the role of a set of TRPV-related ion channels in behaviors. He completed his postdoctoral studies at the University of Washington, developing a genetic screen in zebrafish to probe the host genetic determinants of susceptibility to mycobacterial infection. Tobin currently studies the host response to mycobacterial infection using zebrafish, bacterial, and human genetics.
ICAAC Young Investigator Awardees
Will be honored during the Cubist-ICAAC Lecture.
Tuesday, September 11 | 4:30 p.m. - 5:30 p.m. | Room 103
The 2012 ICAAC Young Investigator Awards recognize and reward five early-career scientists for
their research excellence and potential in microbiology and infectious diseases. Two awards have
been supported by Merck, U.S. Human Health Division since 1983, while two are sponsored by
the ASM. In 2007, an additional award from Merck, U.S. Human Health Division was added
to recognize excellence in HIV research. William P. Hanage and David M. Tobin are the 2012
laureates for the Merck-sponsored awards, and Andrew Lee Lovering and María Soledad
Ramírez are the 2012 laureates for the ASM-sponsored awards. Mario L. Santiago is the
2012 laureate for the Merck-sponsored award for HIV research.
Efficacy and Use of PI vs EFV in Treatment Naive HIV+ Men and Women
J. Patel; Rush Univ. Med. Ctr., Chicago, IL
Safety and Efficacy of Once Daily Raltegravir to Enhance Adherence and Efficacy of HAART in Vulnerable HIV-Infected Patients
K. Stewart; Univ. of Saskatchewan, Saskatoon, Canada
Preemptive Therapy Prevents Cytomegalovirus End-Organ Disease in Treatment-Naïve Patients With Advanced HIV-1 Infection
D. Mizushima; Natl. Ctr. for Global Hlth. and Med., Tokyo, Japan Genotypic Algorithm for Predicting Elvitegravir Susceptibility: Clinical Validation and Correlation with Phenotype
M. Haddad; Monogram Biosciences, South San Francisco, CA
Persistent Low-Level Viraemia in HIV-1-Infected Patients: Swiss HIV Cohort Study
N. Boillat Blanco; Univ., Lausanne, Switzerland
Monday, September 10 | 11:15 a.m.-12:15 p.m.
Daily Infection Prevention and Control Issues
Convener:Loreen Herwaldt, MD
Univ. of Iowa, Coll. of Med., Iowa City, IA
Presentations:
Prosthetic Joint Infection (PJI) Should Be Considered In Prosthetic Failure Within 2 Years of Implantation
M. E. Portillo; Reference Lab. of Catalunya, Barcelona, Spain Hospital-Acquired Influenza in an Australian Sentinel Surveillance System
N. Macesic; Alfred Hlth., Melbourne, Australia
Rapid Screening Tests for MRSA Did Not Decrease Postoperative MRSA Infections in Patients with Inflammatory Bowel Disease (IBD)
Y. Takahashi; Hyogo Coll. of Med., Nishinomiya, Japan
What to Breathe? Performance Analysis of Air Samplers in Operating Rooms
L. Ummels; Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands Characteristics of Septic Arthritis: A Retrospective Study Over 11 Years
L. N. Walti; Univ. Hosp., Lausanne, Switzerland
Poster Walk presentations, selected by the ICAAC Program
Committee, are designed to give poster presenters an
opportu-nity to give brief informal presentations and answer questions on
their research. Lead by pioneers in the field, these topic-based
walks will tour the Poster Hall discussing the most intriguing
posters and latest discoveries from particular areas of interest.
Poster Walks will take place in Halls A-C.
Sunday, September 9 | 11:30 a.m. – 12:30 p.m.
Antibiotic Use and Resistance
Convener:
Stephan Harbarth, MD, MS
Univ. of Geneva Hosp., Geneva, Switzerland
Presentations:
Do Antibiotic Combinations with Rifampin for Osteoarticular Infections Protect against Clostridiumdifficile-Associated Colitis?
C. Landelle; Univ. of Geneva Hosp., Geneva, Switzerland
Outcome of Appropriate Empiric Combination versus Monotherapy for Pseudomonas aeruginosa Bacteremia
D. R. Bowers; St. Luke’s Episcopal Hosp., Univ. of Houston, Houston, TX Clinical Impact of KPC Status and Appropriate Treatment among
Enterobacteriaceae (EB) and Pseudomonas aeruginosa (Pae) in a Multicenter Matched Control Cohort Study in Colombia
V. M. Blanco; CIDEIM, Cali, Colombia, Univ. del Valle, Cali, Colombia
Inadequate Antibiotic Therapy is Associated with Decreased Survival in Patients with Extended-Spectrum Beta-
Lactamase-Producing Enterobacteriaceae Bloodstream Infections
N. F. Dewhurst; St. Michael’s Hosp., Toronto, Canada, Univ. of Toronto, Toronto, Canada
Control of the Prescription of Carbapenems in a French Hospital: Impact of the Hospital Antibiotic Management Team
C. Couzigou; Hosp. Saint-Joseph, Paris, France
Sunday, September 9 | 12:30 p.m.- 1:30 p.m.
he HIV Poster Rounds
Conveners:
Joseph Eron, Jr., MD
Univ. of North Carolina, Chapel Hill, NC
Jean-Michel G. Molina, MD
Saint Louis Hosp. and Univ. of Sorbonne Paris Cité, Paris, France
Presentations:
Impact of Seven Nucleotide Polymorphisms and Haplotypes of CYP2B6 on Plasma Efavirenz Level in HIV/Tuberculosis Co-Infected Thai Patients Receiving Rifampicin
Monday, September 10 | 12:15 p.m. - 1:15 p.m.
Resistance Genes Have No Boundaries!
Conveners:
Lesley McGee, PhD
CDC, Atlanta, GA
Johann D. Pitout, MD
Univ. of Calgary, Calgary, Canada
Presentations:
Molecular Characterization of Multidrug-Resistant
Mycobacterium tuberculosis from Asian Countries
C. Nakajima; Hokkaido Univ. Res. Ctr. for Zoonosis Control, Sapporo, Japan
Extended-Spectrum Beta-Lactamase (ESBL) Producing Gram-Negative Bacteria from Pets, Buffalos and Psittacines, Brazil
L. Barbato; USP, São Paulo, Brazil
Accessory Gene Regulator (AGR) Function, rpoB Mutations and Vancomycin (VA) Susceptibility in Methicillin-Resistant
Staphylococcus aureus (MRSA) Blood Isolates
M. Camoez; Hosp. Univ Bellvitge. UB. IDIBELL, Barcelona, Spain Lack of Impact of Infant PCV Vaccination on Rates of Adult Invasive Pneumococcal Disease in Ontario, Canada
K. Wong; Mount Sinai Hosp., Toronto, Canada
Current Status of Group B Streptococci (GBS) in Japan -Penicil-lin-Resistant GBS is Emerging in Japan?
H. Mikamo; Aichi Med. Univ., Aichi, Japan
Dissemination of Diverse Plasmids Bearing blaKPC Among Carbapenem-Resistant Enterobacteriaceae (CRE) Different from
Klebsiella spp. in a Hospital System in Cleveland
F. Perez; VAMC, CWRU, Cleveland, OH
Tuesday, September 11 | 11:15 a.m. - 12:15 p.m.
New Developments in Transplantation
Convener:
Emily A. Blumberg, MD
Perelman Sch. of Med., Univ. of Pennsylvania, Philadelphia, PA
Presentations:
Refractory KPC Carbapenemase-Producing Klebsiella pneumoniae
Bacteremia is Tolerated by Solid Organ Transplant Patients (SOT Pts)
C. Clancy; Univ. of Pittsburgh and VA Pittsburgh, Pittsburgh, PA Chronic High EBV Load Carriage has Low Predictive Value to Detect Post-Transplant Lymphoproliferative Disorder (PTLD) in Solid-Organ Transplant Recipients
C. Gardiol; Univ. Hosp. Ctr. of Lausanne, Lausanne, Switzerland Risk Factors and Outcomes of Bacteremia Caused by Drug-Resistant ESKAPE Pathogens in Solid Organ Transplant (SOT) Recipients
M. Bodro; IDIBELL Biomedical Res. Inst., Hosp. Llobregat, Barcelona, Spain
The Molecular Epidemiology of a Respiratory Syncytial Virus Outbreak Among Oncology and Hematopoietic Stem Cell Transplant (HSCT) Patients
H. Y. Chu; Univ. of Washington, Seattle, WA
Diagnosis of Invasive Aspergillosis and Mucormycosis Guided by PCR Assays from Bronchoalveolar Lavage Fluid in Allogenic Stem Cell Recipients
H. Lellek; Univ. Hosp. Hamburg-Eppendorf, Hamburg, Germany
Tuesday, September 11 | 12:15 p.m. - 1:15 p.m.
Fungal Infections at the Bedside
Convener:
John Perfect, MD
Duke Univ. Med. Ctr., Durham, NC
Presentations:
The Clinical Course Following the Use of Corticosteroids for Symptomatic Relief of Primary Pulmonary Coccidioidomycosis in Immunocompetent Persons
N. Azadeh; Mayo Clinic, Phoenix, AZ
Effectiveness of Posaconazole Vs Fluconazole as Antifungal Prophylaxis in Hematology-Oncology Patients at Duke University Hospital (DUH) 2004-2010
H. C. Kung; Duke Clinical Res. Inst., Durham, NC
Pilot Prospective Study of High Dose (10 mg/kg/d) Liposomal Amphotericin B (L-AmB) for the Initial Treatment of Mucormycosis: AMBIZYGO Trial
F. Lanternier; Hosp. Necker Enfants Malades, Paris, France; Inst. Pasteur, Paris, France
Systemic Candidiasis Increased Mortality in ICU Infected Patients with Cirrhosis
H. Dupont; Pole d’Anesthesie-Reanimation, CHU d’Amiens, Amiens, France
The Tolerability of Amphotericin B Lipid Complex Formulation in Patients With Severe Infusion Reactions to Liposomal Amphotericin B
D. Farmakiotis; MD Anderson Cancer Ctr., Houston, TX
Albornoz, Ezequiel, Inst. Natl. de Enfermedades Infecciosas ANLIS Dr. G. Malbran, Buenos Aires, Argentina
Poster Session 087, Presentation C2-701
Alraddadi, Basem, Tufts Med. Ctr., Medford, MA Poster Session 113, Presentation T-1025
Beyda, Nicholas, Univ. of Houston Coll. of Pharmacy, Houston, TX Poster Session 028, Presentation M-316
Bhalla, Preeti, Oregon Hlth. & Sci. Univ., Portland, OR Poster Session 029, Presentation T-345
Bhalodi, Amira, Hartford Hosp., Hartford, CT
Poster Session 003, Presentation A-020; Poster Session 083, Presentation A-625; Poster Session 163, Presentation A-1287
Bhargava, Ashish, Detroit Med. Ctr., Wayne State Univ., Detroit, MI Poster Session 008, Presentation C2-096
Briggs, Heather, Univ. of Texas Hlth. Sci. Ctr. at San Antonio, TX Poster Session 172, Presentation D-1449
Butterfield, Jill, Albany Coll. of Pharmacy and Hlth. Sci., Albany, NY Poster Session 082, Presentation A-606
Chen, Hong, Ctr. for Hlth. Protection, Hong Kong, China Poster Session 021, Presentation K-243
Cheng, Ying, Natl. Inst. for Communicable Disease Control and Prevention, Sklid, China Poster Session 105, Presentation K-936
Chu, Helen, Univ. of Washington, Seattle, WA Poster Session 029, Presentation T-353
Commons, Robert, Royal Darwin Hosp., Northern Territory, Australia Poster Session 165, Presentation B-1313
Dilworth, Thomas, Univ. of New Mexico Coll. of Pharmacy, Albuquerque, NM Poster Session 174, Presentation E-1472
Frere, Julie, CHU Sainte-Justine, Montreal, Canada Poster Session 178, Presentation G3-1554
Gillis, Louise-Marie, Univ. of Pittsburgh Med. Ctr., Pittsburgh, PA Poster Session 094, Presentation E-786; Poster Session 183, Presentation K-1605
Gillman, Jason, UT Southwestern Med. Ctr., Dallas, Texas Poster Session 029, Presentation T-357
Goldblatt, Jennifer, Imperial Coll. London, London, United Kingdom Poster Session 165, Presentation B-1311
Housman, Seth, Ctr. Anti-Infect. Res. & Devel., Hartford Hosp., Hartford, CT Poster Session 003, Presentation A-022
Jaber, Mohammad, Chu Sainte Justine, Montreal, QC, Canada Poster Session 030, Presentation V-376
Jacobson, Shauna, West Virginia Univ. Hosp., Morgantown, WV Poster Session 105, Presentation K-928
Karadag Oncel, Eda, Hacettepe Univ. Med. Faculty, Ankara, Turkey Poster Session 240, Presentation A-1941
Kasper, Douglas, Med. Coll. of Wisconsin, Milwuakee, WI Poster Session 090, Presentation D-728
Kelesidis, Theodoros, David Geffen Sch. of Med., Los Angeles, CA
Kestler Hernandez, Martha, Hosp. Gen. Univ. Gregorio Marañon, Madrid, Spain Poster Session 023, Presentation K-263; Poster Session 106, Presentation K-940
Kwa, Andrea, Univ. of Pittsburgh, Pittsburgh, PA
Poster Session 015, Presentation E-195; Poster Session 094, Presentation E-791; Poster Session 174, Presentation E-1476
Lee, Yu-Mi, Asan Med. Ctr., Seoul, Korea, Republic of Poster Session 091, Presentation D-741
Lee, Yeon Joo, Memorial Sloan-Kettering Cancer Ctr., New York, NY Poster Session 029, Presentation T-361
Leistner, Rasmus, Charité Univ., Berlin, Germany Poster Session 181, Presentation K-1592
Luther, Megan, Veterans Affarirs Med. Ctr., Providence, RI Poster Session 173, Presentations E-1464, E-1469
Phee, Lynette, Barts Hlth. NHS Trust, London, United Kingdom Poster Session 092, Presentation D-761; Poster Session 094, Presentation E-797
Pittet, Laure, Univ. Hosp. of Geneva, Switzerland Poster Session 178, Presentation G3-1556
Pupaibool, Jakrapun, Mayo Clinic, Rochester, MN Poster Session 096, Presentation F-813
Rao, Gauri, SUNY, Buffalo, NY
Poster Session 004, Presentation A-024; Poster Session 094, Presentation E-785
Rao, Krishna, Univ. of Michigan Hlth. Systems, Ann Arbor, MI Poster Session 105, Presentation K-926
Reuland, Elien Ascelijn, VU Univ. Med. Ctr., Amsterdam, Netherlands Poster Session 009, Presentation C2-104
Sadarangani, Manish, Univ. of British Columbia and BC Children’s Hosp., Vancouver, Canada
Poster Session 178, Presentations G3-1542, G3-1544
Satyanarayana, Gowri, Beth Israel Deaconess Med. Ctr., Boston, MA Poster Session 029, Presentation T-354
Schmitt, Bryan, Mayo Clinic, Rochester, MI Slide Session 201, Presentation D-1774
Sharff, Katie, Oregon Hlth. and Sci. Univ., Portland, OR Poster Session 171, Presentation D-1432
Sheth, Prameet, Univ. of Toronto, Toronto, Canada Poster Session 008, Presentation C2-089
Soltani, Banafsheh, Temple Univ. Hosp., Philadelphia, PA Poster Session 188, Presentation L1-1656
Soon, Rachel L., Univ. at Buffalo, Buffalo, NY
Poster Session 015, Presentation E-201; Poster Session 082, Presentation A-605; Slide Session 200, Presentation A-1762
Stevens, Vanessa, SUNY Buffalo Sch. of Pharmacy and Pharmacutical Sci., Buffalo, NY Poster Session 082, Presentation A-617
Suwantarat, Nuntra, Case Western Reserve Univ., Cleveland, OH Poster Session 087, Presentation C2-686
Supported by educational grants from ASM, Gilead US, Pfizer Australia, and 3M.
The American Society for Microbiology has long been committed to the educational development of young professionals within the
infectious disease arena. This year, the ASM is please to host again the ID fellows Grant Program supported by educational grants
from ASM, Gilead US, Pfizer Australia, and 3M. This program offers ID Fellows a unique opportunity to attend ICAAC 2012 and
participate in an educational experience specifically tailored to their educational development needs. This select group of Fellows
was nominated by their Program Directors and will have the opportunity to hear a targeted keynote talk and an overview of
recom-mended sessions for attendance, interact with ICAAC Program Committee members and ASM Officers, and be offered
personal-ized attention and daily discussion.
Achermann, Yvonne, Univ. Hosp. Zurich, Switzerland Slide Session 129, Presentation K-1125
Albur, Mahableshwar, North Bristol NHS Trust, Bristol, United Kingdom Poster Session 092, Presentation D-763; Poster Session 094, Presentation E-793
Amit, Sharon, Tel-Aviv Sourasky Med. Ctr., Tel-Aviv, Israel Poster Session 184, Presentation K-1609
Asuphon, Orarik, Nareasuan Univ. Meung Pitsanulok, Phayao, Thailand Poster Session 162, Presentation A-1279
Ballesté Delpierre, Clara, Ctr. en Salut Internacional de Barcelona, Barcelona, Spain Poster Session 087, Presentation C2-696
Cubero, Meritxell, Hosp. Univ. de Bellvitge, Barcelona, Spain Poster Session 087, Presentation C2-690
Daniels, Kelly, The Univ. of Texas, San Antonio, TX Poster Session 026, Presentation L1-297
Duval, Raphael, Univ. de Lorraine, Nancy, France Poster Session 177, Presentation F-1527
Espinal, Paula, Hosp. Clinic-CEK, Barcelona, Spain
Poster Session 016, Presentation, B-1327; Slide Session 236, Presentation C2-1900
Farmakiotis, Dimitrios, Baylor Coll. of Med., MD Anderson Cancer Ctr., Houston, TX Poster Session 191, Presentation M-1705
Ghebremedhin, Beniam, Med. Mirobiol., Magdeburg, Germany Poster Session 009, Presentation C2-108
Girometti, Nicolo, Policlinico S. Orsola-Malpighi, Bologna, Italy Poster Session 184, Presentation K-1619
Gomez, Sonia Alejandra, ANLIS-Dr Carlos G. Malbran, Buenos Aires, Argentina Poster Session 008, Presentation C2-084
Goncalves Quiles, Milene, Federal Univ. of Sao Paulo, Brazil Poster Session 170, Presentation D-1412
Hung, Wei-Chun, Niigata Univ. Graduate Sch. of Med. and Dental Sciences, Niigata, Japan Poster Session 166, Presentation C1-1340
Khan, Adnan, Univ. of Karachi, Karachi, Pakistan Poster Session 243, Presentation C2-1981
Kim, Chung-Jong, Seoul Natl. Univ. Hosp., Seoul, Korea, Republic of Poster Session 104, Presentation K-908
King, Travis, Univ. of Mississippi Med. Ctr., Jackson, MI Poster Session 111, Presentation M-968
Macesic, Nenad, Alfred Hlth., Prahran, Australia Poster Session 108, Presentation K-952
Moon, Song Mi, Asan Med. Ctr., Seoul, Korea, Republic of Slide Session 160, Presentation V-1239
Morency-Potvin, Philippe, Univ. de Montreal, Montreal, Canada Poster Session 090, Presentation D-730
Munier, Anne-Lise, Hosp. Saint Louis, Paris, France
Poster Session 019, Presentation H-219; Poster Session 169, Presentation C2-1399
Munita, Jose, Univ. of Texas at Houston Med. Sch., Houston, TX Poster Session 166, Presentation C1-1345
Muvunyi, Mambo-Claude, National Univ. of Rwanda, National Reference Laboratory, Huye, Rwanda
Poster Session 092, Presentation D-775
Pascual, Vanesa, Hosp. Univ. Mutua de Terrassa, Barcelona, Spain Poster Session 184, Presentation K-1621
Pino, Marylu, Facultad de Farmacia y Bioquimica, Buenos Aires, Argentina Slide Session 047, Presentation C1-466; Poster Session 086, Presentation C1-678
Pouch, Stephanie, NY Presbyterian, Columbia Univ. Med. Ctr., NY Poster Session 113, Presentations T-1034, T-1036
Seyedmousavi Tasieh, Seyedmojtaba, Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands
Poster Session 111, Presentation M-989
Shahrooei, Mohammad, Lab. for Experimental and Clin. Microbio., Leuven, Belgium Poster Session 252, Presentation K-2094
Shallcross, Laura, Univ. College London, London, United Kingdom Poster Session 186, Presentation L1-1645
Sivagnanam, Shobini, Nepean Hosp., Sydney, Australia Poster Session 190, Presentation M-1680
Sole Guiu, Mar, CRESIB, Barcelona, Spain Poster Session 006, Presentation C1-075
Tamayo-Legorreta, Elsa, Natl. Inst. Public Hlth., Cuernavaca, Morelos, Mexico Poster Session 006, Presentation C1-069
Tsai, MaoSong, Natl. Taiwan Univ. Hosp., Taipei, Taiwan, Province of China Poster Session 180, Presentation H-1578
Valerio, Maricela, Hosp. Gen. Gregorio Marañon, Madrid, Spain Slide Session 159, Presentation M-1232; Poster Session 190, Presentation M-1684
Vila, Xavier, Hosp. Clinic, Barcelona, Spain Poster Session 249, Presentation F-2068
The ASM ID Fellows Travel Grant program was established to support the travel of ID Fellows to the annual Interscience
Conference on Antimicrobial Agents and Chemotherapy. The ICAAC Program Committee is pleased to announce that the
following individuals were awarded travel grants. All of this year’s recipients have been designated as George McCracken
Infectious Disease Fellows, in recognition of Dr. McCracken’s efforts to facilitate financial support for these grants.
ICAAC 2012 George McCracken ID Fellows Grant Recipients:
ASM Infectious Diseases (ID) Fellow
Travel Grants
>
Teh, Benjamin, Royal Melbourne Hosp., Parkville, Australia Poster Session 113, Presentation T-1027
Tulliano, Gianfranco, NYU School of Medicine, New York, NY Poster Session 024, Presentation K-273
Werth, Brian, Wayne State Univ., Detroit, MI Poster Session 083, Presentation A-627
Williamson, Deborah, Department of Clin. Microbiology, Auckland, New Zealand Poster Session 178, Presentation G3-1555; Slide Session 237, Presentation C2-1908
Wilmer, Amanda, Univ. of British Columbia, Vancouver, British Columbia, Canada Poster Session 011, Presentation D-161; Poster Session 182, Presentation K-1593
Wongkulab, Panuwat, Chiang Mai Univ., Chiang Mai, Thailand Poster Session 170, Presentation D-1406
Xu, Hua, ShanDong Provincial Hosp., Jinan, China Poster Session 023, Presentation K-268
Zhou, Qing, Zhongshan Hosp. Fudan Univ., Shanghai, China Poster Session 023, Presentation K-269
Zimmerman, Ofer, Tel Aviv Sourasky Med. Ctr., Tel Aviv, Israel Slide Session 115, Presentation M-1059
The ASM Student and Post-Doctoral Travel Grant program was established to support the travel of students and fellows
to ASM meetings. Recipients are selected by the ICAAC Program Committee on the basis of the scientific quality of
their submitted abstracts.
ICAAC 2012 Student and Post-Doctoral Travel Grant Recipients:
Baietto, Lorena, Univ. of Turin, Turin, Italy
Slide Session 200, Presentation A-1769; Poster Session 090, Presentation A-1937
Berti, Andrew, Univ. of Wisconsin, Sch. of Pharmacy, Madison, WI Poster Session 174, Presentation E-1482
Blanco, Victor M., Intl. Ctr. for Med. Res. and Training (CIDEIM), Cali, Colombia Poster Session 092, Presentation D-747; Poster Session 104, Presentation K-903; Poster Session 255, Presentation L2-2108
Casapao, Anthony, Wayne State Univ., Anti-Infective Res. Lab., Detroit, MI Poster Session 024, Presentation K-275; Poster Session 106, Presentation K-946; Slide Session 129, Presentation K-1123
Chan, Albert, UCLA, Los Angeles, CA Poster Session 177, Presentation F-1534
Cotton, Gemma, Univ. of Lincoln, Lincoln, United Kingdom Poster Session 246, Presentation F-2001
Denisuik, Andrew, Univ. of Manitoba, Winnipeg, Canada
Poster Session 009, Presentation C2-103; Poster Session 015, Presentation E-194
Deslouches, Berthony, Univ. of Pittsburgh, Ctr. for Vaccine Res., Pittsburgh, PA Poster Session 249, Presentation F-2061
Dumkow, Lisa, Henry Ford Hosp., Detroit, MI Poster Session 020, Presentation K-240
Fehlberg, Lorena Cristina, Univ. Federal de São Paulo, São Paulo, Brazil Poster Session 090, Presentation D-731; Slide Session 156, Presentation C1-1207
Finn, Talya, Tel Aviv Med. Ctr., Tel Aviv, Israel Poster Session 111, Presentation M-985
Ghantoji, Shashank, MD Anderson Cancer Ctr., Houston, TX Poster Session 105, Presentation K-934
Grare, Marion, Lab. de Bactériologie-Hygiène, Toulouse, France Poster Session 092, Presentation D-758; Poster Session 177, Presentation F-1527
Hall, Ashley, Wayne State Univ., Detroit, MI Poster Session 082, Presentations A-601, A-602
Heimann, Sebastian, Univ. Hosp. of Cologne, Clinic I for Internal Med., Div. of Infectious Disease, Cologne, Germany
Slide Session 159, Presentation M-1230; Poster Session 191, Presentation M-1706
Hoenigl, Martin, Med. Univ. of Graz, Section of Infectious Diseases, Graz, Austria Poster Session 170, Presentation D-1404; Poster Session 112, Presentation P-1009
Huang, En, The Ohio State Univ., Columbus, OH Poster Session 176, Presentation F-1508
Lin, Yu-Tzu, Dept. of Clin.Lab. Sci.and Med. Biotechnology, Taipei, Taiwan, Province of China
Poster Session 166, Presentation C1-1339
Ly, Neang, Univ. of Buffalo, Buffalo, NY Poster Session 003, Presentation A-016
Mahajan, Sminil, UT MD Anderson Cancer Ctr., Houston, TX
Martins Bispo, Paulo Jose, Federal Univ. of Sao Paulo, Sao Paulo, Brazil Poster Session 169, Presentation C2-1400; Poster Session 174, Presentation E-1481
Maya, Juan J., Intl. Natl. Ctr. for Med. Res. and Training, Cali, Colombia Poster Session 092, Presentation D-747; Poster Session 104, Presentation K-903; Poster Sesion 255, Presentation L2-2108
Melchers, Maria, Radboud Univ. Nijmegen Med. Centre, Nijmegen, Netherlands Poster Session 015, Presentation E-190; Poster Session 094, Presentation E-803
Milillo, Michael, Walter Reed Army Inst. of Res., Silver Spring, MD Slide Session 237, Presentation C2-1914
Montassier, Emmanuel, UFR Med., Univ. of Nantes, Nantes, France Poster Session 025, Presentation L1-285; Poster Session 172, Presentation D-1458; Poster Session 186, Presentation L1-1642
Muraleedharan, Chithra, Oakland Univ., Rochester, MI Poster Session 088, Presentation C2-703
Nair, Rajeshwari, Univ. of Iowa, Coralville, IA Poster Session 169, Presentation C2-1384
Peterson, Eliza, Univ. of North Carolina, Chapel Hill, NC Poster Session 177, Presentation F-1535
Rogers, Benjamin, The Univ. of Queensland, Herston, Brisbane, Australia Poster Session 087, Presentation C2-689
Rojo, Andrea, Clin. Univ. de Navarra, Pamplona, Spain Poster Session 171, Presentations D-1439, D-1440
Ryan, Keenan, Univ. of New Mexico Coll. of Pharmacy, Albuquerque, NM Slide Session 197, Presentation C1-1742
Serrano-Villar, Sergio, Hosp. Univ. Ramón y Cajal, Madrid, Spain Poster Session 018, Presentation H-217; Poster Session 179, Presentation H-1567
Simner, Patricia, Mayo Clinic, Rochester, MN Poster Session 190, Presentation M-1691
Trang, Michael, Univ. at Buffalo, Buffalo, NY Poster Session 003, Presentation A-012
Trivedi, Ashit, Univ. of Tennessee Hlth. Sci. Ctr., Memphis, TN Poster Session 161, Presentation A-1267
Walti, Laura, CHUV, Lausanne, Switzerland
Poster Session 012, Presentation D-168; Poster Session 022, Presentation K-250; Poster Session 250, Presentation K-2073
Wendel, Sarah, Natl. Inst. of Allergy and Infectious Diseases, Natl. Inst. of Hlth., Baltimore, MD
Poster Session 180, Presentation H-1580
Winkler, Marisa, Case Western Reserve Univ., Cleveland, OH Slide Session 047, Presentation C1-463; Slide Session 156, Presentation C1-1209
Zhao, Yuyun, Tsinghua Univ., Beijing, China Poster Session 246, Presentation F-2002
ASM Student & Post-Doctoral Fellow
Travel Grants
>
, Inst. for Clin. PharmacoDynamics (ICPD), Latham, NY Poster Session 161, Presentations A-1261, A-1263
Yakubchyk, Yury, SUNY Stony Brook, SBUMC Pediatric ID, Stony Brook, NY Poster Session 112, Presentation P-997
ASM Career Connections
ASM Career Connections will be onsite at ICAAC. Leverage your meeting attendance by
searching job postings and applying for jobs as a candidate, or post job openings and contact
qualified candidates as an employer. Identify candidates and employers attending the meeting and
schedule onsite interviews. Learn more at www.asmcareerconnections.org.
ASM Journals
ASM journals, available in both online and print formats, remain a critical source of high-quality
clinical microbial content. Our journals are some of the most-cited serials within their disciplines,
covering antimicrobial agents, immunology, chemotherapy, clinical microbiology, molecular
biology, pharmacology, virology, and more.
For more information about publishing in an ASM journal, please visit the ASM Journals Booth
#1513 in the Exhibit Hall. Additional submission information is available on the Authors tab at
www.journals.asm.org.
ASM Press Bookstore
ASM Press, the book publishing division of the American Society for Microbiology, will be
selling a broad selection of textbooks, references, manuals, and general interest titles in the ASM
Press Bookstore, located in the main entrance of the South Lobby. ASM Members receive a
20-50% discount on all purchases made at the meeting. Non-members receive a 10% discount
on all purchases made at the meeting.
Membership
Advance with ASM Membership
In 2013 ASM will change its member categories to address the needs of an increasingly diverse
scientific audience—including infectious disease and other clinical professionals. For more
information about the new member types and benefits, visit asm.org/advance or stop by the
Membership Booth (#1106) on the exhibit floor. ICAAC attendees can join or renew for 2013
onsite. For additional information on membership in ASM, call (202) 942-9319 or e-mail
Press Room and ICAAC Live
Media representatives interested in obtaining releases on selected papers and scheduling
interviews can do so in the Press Room, Esplanade Ballroom 301. Daily press conferences and
media interviews of researchers will also take place as part of ICAAC Live in Esplanade
Ballroom 303. ICAAC Live will be moderated by Dr. Jeff Fox, Features Editor for
Microbe
Convention Center
Maps
1. Hotel Abri
127 Ellis Street
San Francisco, CA 94102 (415) 392-8800
2. Courtyard by Marriot Downtown
299 Second Street San Francisco, CA 94105 (415) 947-0700
3. Fairmont San Francisco
950 Mason Street San Francisco, CA 94108 (415) 772-5000
4. Galleria Park Hotel, a Joie De Vivre
Hotel
191 Sutter Street San Francisco, CA 94104 (415) 781-3060
5. Grand Hyat San Francisco
345 Stockton Street San Francisco, CA 94108 (415) 398-1234
6. Handlery Union Square Hotel
351 Geary Street San Francisco, CA 94102 (415) 781-7800
7. Hilton San Francisco Union Square
333 O’Farrell Street San Francisco, CA 94102 (415) 771-1400
8. Holiday Inn Civic Center
50 8th Street
San Francisco, CA 94103 (415) 626-6103
9. InterContinental San Francisco
888 Howard Street San Francisco, CA 94103 (415) 616-6500
10. JW Marriot San Francisco Union Square
500 Post Street
San Francisco, CA 94102 (415) 771-8600
11. King George Hotel
334 Mason Street San Francisco, CA 94102 (415) 781-5050
12. Marriot Union Square-San Francisco
480 Sutter Street San Francisco, CA 94108 (415) 398-8900
13. Hotel Nikko San Francisco
222 Mason Street San Francisco, CA 94102 (415) 394-1111
14. Palace Hotel
2 New Montgomery Street San Francisco, CA 94105 (415) 512-1111
15. Hotel Palomar
12 4th Street
San Francisco, CA 94503 (415) 348-1111
16. Parc 55 Wyndham San Francisco – Union Square
55 Cyril Magnin Street San Francisco, CA 94102 (415) 392-8000
17. he Powell Hotel
28 Cyril Magnin Street San Francisco, CA 94102 (415) 398-3200
18. San Francisco Marriot Marquis
55 4th Street
San Francisco, CA 94102 (415) 896-1600
19. Serrano Hotel (Kimpton)
405 Taylor Street San Francisco, CA 94102 (415) 885-2500
20. Sir Francis Drake Hotel (Kimpton)
450 Powell Street San Francisco, CA 94102 (415) 392-7755
21. Hotel Union Square
114 Powell Street San Francisco, CA 94102 (415) 397-3000
22. Villa Florence Hotel
225 Powell Street San Francisco, CA 94102 (415) 397-7700
23. W San Francisco
181 3rd Street
San Francisco, CA 94103 (415) 777-5300
24. he Westin San Francisco Market Street
50 Third Street
San Francisco, CA 94103 (415) 974-6400
25. he Westin St. Francis
335 Powell Street San Francisco, CA 94102 (415) 397-7000
ICAAC 2012 Hotel
Information
6 - Handlery Union Square Hotel 19 - Serrano Hotel
7 - Hilton San Francisco Union Square 20 - Sir Francis Drake Hotel
8 - Holiday Inn Civic Center 21 - Hotel Union Square
9 - InterContinental San Francisco 22 - Villa Florence Hotel
6
Hotels and Boarding Locations
Please allow for adequate travel time to accommodate for possible
delays due to distance, traffic conditions, etc.
Route #1 . . . Boarding Location
Hilton Union Square San Francisco . . . Curbside on Taylor Street Holiday Inn Civic Center . . . Curbside on 8th Street Hotel Nikko . . . At Hilton Union Square King George Hotel . . . At Hilton Union Square Serrano Hotel . . . At Hilton Union Square Villa Florence Hotel . . . At Hilton Union Square
Service every 15-20 minutes at all times.
Route #2 . . . Boarding Location
Galleria Park Hotel . . . At Westin St. Francis Grand Hyat San Francisco . . . At Westin St. Francis Handlery Union Square . . . At Westin St. Francis JW Marriot San Francisco Union Sq. . . . At Westin St. Francis Marriot Union Square . . . At Westin St. Francis Sir Francis Drake . . . At Westin St. Francis Westin St. Francis . . . Curbside on Post
Service every 15-20 minutes at all times.
Route #3 . . . Boarding Location
Fairmont San Francisco . . . Curbside on Mason
Service every 15-20 minutes at all times.
Satellite Symposia Shutle Hours
Symposia will be located at the Marriott Marquis and the
Intercontinental. SHUTTLE SERVICE WILL NOT BE
PROVIDED.
Convention Center Shutle Hours Moscone
Convention Center
Service is every 15-20 minutes at all times.
Saturday, September 8 . . . 7:30 a.m. – 5:30 p.m.* Sunday, September 9 . . . 6:00 a.m. – 7:00 p.m.* Monday, September 10 . . . 6:00 a.m. – 7:30 p.m.* Tuesday, September 11 . . . 6:00 a.m. – 7:30 p.m.* Wednesday, September 12 . . . 6:30 a.m. – 12:30 p.m.*
*Indicates last time shuttle departs Moscone Convention
Center returning to hotels. Last shuttle departs hotels
coming to Moscone approximately 45 minutes prior to this time.
If you have questions about the shuttle
or if you need to make an advance
reservation for a wheelchair-accessible
shuttle, please see the supervisor at the
Moscone Convention Center or call
KUSHNER & ASSOCIATES at
(310) 274-8819 ext. 213.
>
>
>
he following hotels are located within walking distance of Moscone Convention Center, therefore, shutle service is NOT provided.
Hotel Abri
Courtyard by Marriot Downtown Hotel Palomar
Hotel Union Square
InterContinental San Francisco Marriot Marquis San Francisco Palace - Luxury Starwood Parc 55 Wyndham Powell Hotel
W Hotel San Francisco
Westin San Francisco Market Street
Shutle
Information
>
Abstract Compilations
Exhibiting companies that distribute abstract compilations
on-site of any of the ICAAC 2012 abstract presentations must have
received prior approval from the Program Committee and ASM.
Compilations most accurately reflect the abstracts and cannot
contain promotional information. Pre-approved distribution is
allowed from a specially designated literature rack in Halls A-C
at the Poster Information booth. Abstract compilations
distrib-uted in an unapproved area will be removed by ASM staff.
Abstracts on CD-ROM
Supported by Merck & Co, Inc.
All ICAAC 2012 Abstracts have been compiled on a fully
searchable CD-ROM that will be included in each
registra-tion bag.
Americans with Disabilities Act
Special Services at Moscone North and South
Persons requiring special services at the convention center
(wheelchair-accessible transportation, sign interpreters, etc.)
are asked to stop by ASM Headquarters in Room 220. Since
requests were due as part of the registration process, on-site
requests will be fulfilled based on availability.
ATM
There is an ATM located in Moscone North near the entrance
to Hall D, and one in Moscone South outside of Hall B.
Badge Policies
For security reasons, all attendees are required to wear a badge
to attend sessions or enter the Exhibit Hall. Please note that
badges are the property of ASM and must be relinquished at any
time at the request of ASM staff or security.
Atendee Badges
>
Access into all scientific sessions
>
Access to the Exhibit Hall and Poster Sessions during
operating hours
>
Unlimited use of the courtesy shuttle
>
Access to Continuing Education Credits
Guest Badges
>
Access to the Exhibit Hall and Poster Sessions during
operating hours
>
Unlimited use of the courtesy shuttle
>
Attendees wearing guest badges will not be permitted into
scientific session rooms.
Exhibitor Badges
>
Entrance into the Exhibit Hall during installation and
dismantling hours
>
Entrance into the Hall 2 hours before the Hall opens and
one hour after it closes
>
Unlimited use of the courtesy shuttle
>
Attendees wearing exhibitor badges will not be permitted into
scientific session rooms.
Press Badges
>
Access into all scientific sessions
>
Access to the Exhibit Hall and Poster Sessions during
operating hours
>
Unlimited use of the courtesy shuttle
>
To receive continuing education credit, members of the
press must register for the meeting and pay the
appropri-ate registration fee
Badge Replacement Policy
Replacement badges are $100. Please return any found
badges to the Registration Assistance Counter located in
Hall A-B, Exhibit Level of Moscone Convention Center
South.
Security and Badge Duplication or Sharing
Business Center
The Business Center in Moscone South offers numerous
ser-vices, including digital printing, packing & shipping, packaging
materials, and last-minute office supplies, to meet your needs.
Location
Moscone South, near the entrance to Hall C
Phone: (415) 974-4067
Fax: (415) 974-4052
Hours:
Sunday, September 9
>
10:30 a.m. – 4:30 p.m.
Monday, September 10
>
9:30 a.m. – 4:30 p.m.
Tuesday, September 11
>
9:30 a.m. – 4:30 p.m.
Wednesday, September 12
>
9:00 a.m. – 12:00 p.m.
Cameras and Recording
Cassette recorders, cameras (including camera phones, and video
cameras) are
NOT
allowed in session rooms or in the exhibit
and poster areas. Attendees who wish to purchase a digital
re-cording of a session may stop by the Multimedia Booth located
in the South Lobby.
Certiicate of Atendance
A Certificate of Attendance will be available beginning Monday,
September 10 at all attendee registration counters.
Child Safety
Children are not permitted entry into session rooms. Also,
children under the age of 18 are not permitted on the Exhibit
Hall floor during setup or dismantling hours. During scheduled
show hours, exceptions are made when parents or guardians
complete and sign a Minor Release Form. This form is available
in the ICAAC Information Booth in the South Lobby and in
the ICAAC Headquarters Office in Room 220. Strollers are not
allowed in the Exhibit Hall and may be checked at the coat and
baggage check.
Coat and Baggage Check
A coat and baggage check is located on the Mezzanine level, just
below the South Lobby.
Hours:
Sunday, September 9
>
7:00 a.m. – 6:30 p.m.
Monday, September 10
>
7:00 a.m. – 7:00 p.m.
Tuesday, September 11
>
7:00 a.m. – 7:00 p.m.
Wednesday, September 12
>
7:00 a.m. – 12:00 p.m.
Cooperating Organizations
>
American Society of Tropical Medicine and Hygiene
(ASTMH)
>
European Organisation for Research and Treatment of
Cancer (EORTC-IDG)
>
European Society of Clinical Microbiology and Infectious
Diseases (ESCMID)
>
Global Chinese Association of Clinical Microbiology and
Infectious Diseases (GCACMID)
>
Infectious Diseases Society of America (IDSA)
>
Infectious Diseases Society of Obstetrics and Gynecology
(IDSOG)
>
International Antiviral Society-USA (IAS-USA)
>
International Society of Anti-Infective Pharmacology
(ISAP)
>
International Society of Chemotherapy (ISC)
>
Mycology Study Group (MSG)
>
Pediatric Infectious Diseases Society (PIDS)
>
Society of Infectious Diseases Pharmacists (SIDP)
>
Surgical Infection Society (SIS)
E-Central
The following services and information are available:
>
Obtain a continuing education certificate
>
ASM CE Portal access
>
Locate presenters, sessions and topics
>
E-mail access
Locations :
E -Central #1
| Hall E Foyer
Saturday, September 8
>
12:00 p.m. – 5:00 p.m.
Sunday, September 9
>
6:30 a.m. – 6:30 p.m.
Monday, September 10
>
6:30 a.m. – 7:00 p.m.
Tuesday, September 11
>
6:30 a.m. – 7:00 p.m.
Wednesday, September 12
>
6:30 a.m. – 12:00 p.m.
E-Central #2
| Halls A-C
Sunday, September 9
>
11:30 a.m. – 4:30 p.m.
Monday, September 10
>
10:30 a.m. – 4:30 p.m.
Tuesday, September 11
>
10:30 a.m. – 4:30 p.m.
microbial agents and chemotherapy. These exhibitors will have
the latest in the field of infectious disease from vaccines,
diag-nostic equipment and services, scientific publications, research,
and new drugs and the latest information on existing drugs.
Please schedule time to walk through the Exhibit Hall and take
advantage of this rare grouping of exhibitors. The Exhibit Hall
is located in Moscone South A-C.
he Exhibit Hall is open:
Sunday, September 9
>
11:30 a.m. – 4:30 p.m.
Monday, September 10
>
10:30 a.m. – 4:30 p.m.
Tuesday, September 11
>
10:30 a.m. – 4:30 p.m.
Exhibit Hall Atractions:
>
Poster Sessions
>
Poster Walks
>
iPosters
>
E-Central
>
Food Court
Refer to the Meeting & Exhibit Guide for detailed information
on specific exhibitors, their products and locations, as well as
ad-ditional information on their industry-sponsored symposia.
when the ExpoCard is used:
In the Exhibit Hall:
the ExpoCard serves as an electronic
busi-ness card, allowing you to easily and quickly leave your address
information for follow-up with companies exhibiting products
that interest you.
E-Central:
you may gain access to the services outlined on page
24 with the swipe of your ExpoCard.
First Aid
A First Aid Station will be staffed at Moscone Center in
Hall C
Foyer
during meeting hours. If you feel ill or need a place to lie
down, go to the First Aid Station. In case of a medical
emergen-cy at Moscone Center, please dial 511 from any house phone.
Food and Beverage
Full service food stands will be available Saturday–Tuesday,
throughout Moscone North and South.
Future Meetings Booth
A bulletin board for posting notices concerning future
meet-ings will be located at the Future Meetmeet-ings Booth in the South
Lobby. Announcements displayed elsewhere will be discarded.
Housing
Any changes to hotel reservations should be made directly
with the hotel. If you have any problems with your reservation
or need to change hotels, please visit the Housing Assistance
Counter located at Registration Assistance in Halls A-C.
Information Booth
The ICAAC Information Booth will be located in the South
Lobby.
he following information will be available:
>
Meeting Information
>
Approved Affiliated Events
>
Program Changes and Updates
Lost and Found
Unattended personal belongings will be removed and taken to
the ICAAC Headquarters Office located in Room 220.
Messages
Mail and other forms of communication can be directed to the
individual at the hotel where he or she is registered.
Multimedia Sales
Digital recordings from ICAAC sessions are available for
purchase in the South Lobby at the multimedia sales booth.
Nursing Room
A Nursing Room will be available for use during ICAAC 2012.
Please visit Headquarters in Room 220 for additional information.
Parking
Moscone Center encourages the use of public transit first.
However, parking facilities do exist close to Moscone. For more
information about nearby garages as well as a parking map,
please visit www.moscone.com/directions/parking.shtml.
Poster Information
Call4Posters™
The Call4Posters™ Booth is located outside Halls A-C.
iPosters™
iPosters is a free of charge service that allows you to include
your poster in the online poster database. iPosters™ online
poster database will be available for viewing during and
after the meeting. iPosters™ kiosks for poster viewing and
printing will be available on-site in Halls A-C. To include
your poster in this educational database, please go to www.
call4posters.com/icaac or visit the iPosters™ kiosks located
in Halls A-C, where staff will be available to accept
elec-tronic submissions of your final poster. Attendees can view
iPosters™ online by visiting the iPosters™ kiosks.
Poster Storage
Complimentary poster storage, for posters and poster
con-tainers only, will be located inside Halls A-C. Posters not
removed from the Poster Storage area will be discarded at the
conclusion of the meeting. All items are stored at your own
risk. ASM is not responsible for lost or stolen items.
Poster Walks
Poster Walk presentati
